Mainstream

Travere Therapeutics Non-GAAP EPS of -$0.47 misses by $0.09, revenue of $74.79M beats by $2.41M

Travere Therapeutics Non-GAAP EPS of -$0.47 misses by $0.09, revenue of $74.79M beats by $2.41M

Post ContenttvtxRead More

You might also be interested in reading 80% of Strategy’s ‘Stretch’ buyers are mom-and-pop investors.

February 20, 2025
In Mainstream